The revised dopamine hypothesis of schizophrenia: evidence from pharmacological MRI studies with atypical antipsychotic medication.
about
MicroRNA dysregulation in psychiatric diseaseA Role for Oxytocin in the Etiology and Treatment of Schizophrenia.The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue.Brain connectivity studies in schizophrenia: unravelling the effects of antipsychotics.Theranostic Biomarkers for SchizophreniaCSF and brain structural imaging markers of the Alzheimer's pathological cascade.Long-term efficacy and tolerability of quetiapine in patients with schizophrenia who switched from other antipsychotics because of inadequate therapeutic response-a prospective open-label study.Relationship of neurocognitive deficits to diagnosis and symptoms across affective and non-affective psychoses.Acetylcholine α7 nicotinic and dopamine D2 receptors are targeted to many of the same postsynaptic dendrites and astrocytes in the rodent prefrontal cortex.DISC1 genetics, biology and psychiatric illnessSystems biology, bioinformatics, and biomarkers in neuropsychiatry.Calretinin and parvalbumin in schizophrenia and affective disorders: a mini-review, a perspective on the evolutionary role of calretinin in schizophrenia, and a preliminary post-mortem study of calretinin in the septal nuclei.Pluripotent stem cells in neuropsychiatric disorders.
P2860
Q24630375-0D6E6C0D-0E0A-4E26-8B50-FC56AF24599FQ30408983-4149C73D-EC10-42C6-AEF7-5E82514324BDQ30437188-1C2CB6B9-8600-4D1D-8A57-ACC71693A674Q30596256-00354E48-3773-457C-AC85-4F9347E5BB8AQ33624412-3B4FC57E-A601-46D7-999E-F8D53D8797AEQ34531387-BE7ACA74-0CC3-4095-B63C-AA4DA57922D1Q35021026-2B4BFCDF-8412-4F7E-8F18-5B35609BF6EEQ35577541-C40478BC-A269-48CB-B736-0FA899391008Q35975080-D7A86A46-9A68-4A81-9074-4B1DA06CE097Q36634401-2B030F23-9BBC-4F7C-846E-61A9C1CA86EEQ38069972-D3DB6550-90D0-4DE2-8448-6E43B875C522Q38636760-4D543742-E5E3-460F-8B71-877DE984EB56Q39189500-88F9A192-A508-4381-ABBE-CBB1666DD91D
P2860
The revised dopamine hypothesis of schizophrenia: evidence from pharmacological MRI studies with atypical antipsychotic medication.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
The revised dopamine hypothesi ...... ical antipsychotic medication.
@ast
The revised dopamine hypothesi ...... ical antipsychotic medication.
@en
type
label
The revised dopamine hypothesi ...... ical antipsychotic medication.
@ast
The revised dopamine hypothesi ...... ical antipsychotic medication.
@en
prefLabel
The revised dopamine hypothesi ...... ical antipsychotic medication.
@ast
The revised dopamine hypothesi ...... ical antipsychotic medication.
@en
P2093
P1476
The revised dopamine hypothesi ...... pical antipsychotic medication
@en
P2093
Dick Veltman
Fabiana da Silva Alves
Lieuwe de Haan
Therese van Amelsvoort
P304
P577
2008-01-01T00:00:00Z